| |
| |
|
| Insider
Information: |
Baker Charles A |
| Relationship: |
Director |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
30,481 |
|
|
Indirect Shares
|
18,481 |
|
|
| Direct
Value |
$8,036,872 |
|
|
|
Indirect Value
|
$75,772 |
|
|
| Total
Shares |
48,962 |
|
|
| Total
Value |
$8,112,644 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progenics Pharmaceuticals Inc |
PGNX |
Director |
2007-01-29 |
21,481 |
2003-07-03 |
18,481 |
Premium* |
|
|
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2017-09-29 |
9,000 |
2013-11-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2017-09-29 |
4 |
OE |
$18.61 |
$37,220 |
D/D |
2,000 |
11,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2017-09-29 |
4 |
AS |
$450.00 |
$900,000 |
D/D |
(2,000) |
9,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2016-12-12 |
4 |
AS |
$390.67 |
$1,176,048 |
D/D |
(3,000) |
9,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2016-12-12 |
4 |
OE |
$18.61 |
$55,830 |
D/D |
3,000 |
12,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2015-09-17 |
4 |
OE |
$18.61 |
$93,050 |
D/D |
5,000 |
14,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2015-09-17 |
4 |
AS |
$550.00 |
$2,750,000 |
D/D |
(5,000) |
9,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2015-03-25 |
4 |
OE |
$18.61 |
$93,050 |
D/D |
5,000 |
14,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2015-03-25 |
4 |
AS |
$452.45 |
$2,274,785 |
D/D |
(5,000) |
9,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2014-03-24 |
4 |
AS |
$300.09 |
$4,540,001 |
D/D |
(15,000) |
9,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2014-03-24 |
4 |
OE |
$23.84 |
$357,600 |
D/D |
15,000 |
24,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2013-11-26 |
4 |
GD |
$0.00 |
$0 |
I/I |
590 |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2013-09-30 |
4 |
OE |
$19.69 |
$295,350 |
D/D |
15,000 |
24,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2013-09-30 |
4 |
AS |
$302.46 |
$4,710,439 |
D/D |
(15,000) |
9,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2013-06-10 |
4 |
AS |
$250.06 |
$3,777,547 |
D/D |
(15,000) |
9,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2013-06-10 |
4 |
OE |
$15.80 |
$237,000 |
D/D |
15,000 |
24,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2012-11-26 |
4 |
AS |
$171.45 |
$2,607,986 |
D/D |
(15,000) |
9,590 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2012-11-26 |
4 |
OE |
$9.17 |
$137,550 |
D/D |
15,000 |
10,690 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2012-09-06 |
4 |
OE |
$15.01 |
$205,847 |
D/D |
13,714 |
23,304 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2012-09-06 |
4 |
AS |
$150.00 |
$2,057,100 |
D/D |
(13,714) |
9,590 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2012-09-05 |
4 |
AS |
$150.00 |
$192,900 |
D/D |
(1,286) |
9,590 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2012-09-05 |
4 |
OE |
$15.01 |
$19,303 |
D/D |
1,286 |
10,876 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2012-04-19 |
4 |
AS |
$125.00 |
$1,613,750 |
D/D |
(12,910) |
9,590 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2012-04-19 |
4 |
OE |
$18.80 |
$242,708 |
D/D |
12,910 |
22,500 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2012-04-17 |
4 |
AS |
$125.00 |
$261,250 |
D/D |
(2,090) |
9,590 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2012-04-17 |
4 |
OE |
$18.80 |
$39,292 |
D/D |
2,090 |
11,680 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
